Used in targeted cancer therapy, particularly for treating solid tumors such as cervical and ovarian cancers. Binds specifically to tissue factor (TF), a protein overexpressed on tumor cells and tumor vasculature, enabling delivery of cytotoxic agents directly to cancer cells. As an antibody-drug conjugate component, it enhances treatment precision while minimizing damage to healthy tissues. Also under investigation for its role in inhibiting tumor angiogenesis and metastasis through TF pathway modulation.